To find Alzheimer's clinical trials near you, start with a free search tool like the Alzheimers.gov Clinical Trials Finder, run by the National Institute on Aging (NIA), which lets you search by location and interest. You can also search the underlying ClinicalTrials.gov registry, the official NIH database that lists each study's purpose, eligibility, sites, and a contact phone number. A clinical trial is a research study that tests whether a treatment, drug, or care approach is safe and works. This guide explains how to find local trials, who qualifies, what participation costs, and the questions worth asking before you sign anything.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Where to search for local trials
- Who is eligible to join?
- What will it cost?
- Consent, study partners, and questions to ask
- The "therapeutic misconception" warning
- Frequently Asked Questions
Where to search for local trials
Two national tools cover almost every study. The NIA's Clinical Trials Finder searches for trials on Alzheimer's, other dementias, mild cognitive impairment (MCI, memory problems larger than normal aging but short of dementia), general cognitive health, and caregiving. you filter by keyword, location, and the type of study you want. Behind that finder sits ClinicalTrials.gov, the NIH registry maintained with the FDA.
It lists federally and privately funded studies and lets you search by condition, drug, sponsor, or location. Each listing gives the study's goal, its eligibility rules, the exact sites, and staff phone numbers so you can call directly. If online searching feels like too much, the NIA runs a live help line at 800-438-4380. The NIA also funds Alzheimer's Disease Research Centers across the country that match local participants to studies, which is often the fastest route to a trial near home.
Who is eligible to join?
You do not need to have dementia to participate. According to the NIA, studies also need healthy volunteers, caregivers, and family members, and you need not be older to qualify for many of them. That said, every study sets its own inclusion and exclusion criteria — the specific rules for who can and cannot join.
These may cover age, diagnosis stage, other health conditions, current medications, or whether you have a partner who can attend visits. before you get attached to a particular trial, check the listed criteria against your situation. A quick scan for these items saves time:.
- Age range and required diagnosis (or confirmation that healthy volunteers are wanted)
- Disqualifying conditions or medications
- Whether a "study partner" is required (see below)
- How far the study site is and how often you must travel
What will it cost?
Costs vary by study, so confirm every expense with the study coordinator before enrolling. The NIA and Alzheimers.gov FAQ notes that sponsors typically provide the investigational drug and study-specific tests at no charge — but do not assume all care is free. Medicare fills part of the gap.
Under national coverage determination 310.1, Medicare pays the "routine costs" of qualifying trials — your usual care and the treatment of any complications from the trial. It does not pay for the investigational item itself or for services that exist only to collect research data. So a realistic picture is layered: the sponsor covers the experimental treatment and research-only tests, Medicare covers routine care, and you may still face travel, time, or incidental costs. Ask the coordinator to walk through each category before you commit.
Consent, study partners, and questions to ask
Enrollment always includes informed consent. Staff review every study detail, you sign a consent form, and — per the NIA — researchers must keep informing you and answering questions throughout the trial, not just at the start. Ask pointed questions before signing.
Useful ones include: Consent gets more complex when the participant has dementia. A person with advanced disease may need a legal representative or proxy to consent on their behalf. If you are that proxy, make sure you understand the study as fully as the participant would need to.
- What are the possible side effects of the treatment?
- What procedures are involved — MRIs, lumbar punctures (a spinal fluid draw), repeated blood tests?
- How much added care burden and travel does this create?
- Is a "study partner" required — someone who knows the participant well and attends visits?
The "therapeutic misconception" warning
One risk is easy to miss. The NIA cautions that people with Alzheimer's may fall into a "therapeutic misconception" — wrongly assuming that joining a trial is the same as receiving personal treatment tailored to help them.
That assumption can lead someone to underestimate the risks and enroll for the wrong reasons, which undermines genuine informed consent. A trial's first purpose is to answer a research question; any benefit to the individual is uncertain and, in placebo-controlled studies, not guaranteed at all. Keep that distinction clear when you or a loved one weigh whether to sign the consent form.
Frequently Asked Questions
Can caregivers or healthy people join Alzheimer's research?
Yes. The NIA says studies need healthy volunteers, caregivers, and family members, not only people with a dementia diagnosis.
Who can consent if the person has advanced dementia?
A legal representative or proxy may need to consent on their behalf, and many trials also require a study partner who attends visits.
Does Medicare cover trial participation?
Medicare pays routine care costs under coverage determination 310.1, but not the investigational drug or research-only, data-collection services.
